These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11566038)

  • 1. Adverse gastrointestinal effects of NSAIDs: consequences and costs.
    Bidaut-Russell M; Gabriel SE
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):739-53. PubMed ID: 11566038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
    Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
    J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.
    Delcò F; Michetti P; Beglinger C; Fried M; Szucs TD
    Digestion; 2004; 69(1):10-9. PubMed ID: 14755148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID association with gastrointestinal bleeding and peptic ulcer.
    Hirschowitz BI; Lanas A
    Agents Actions Suppl; 1991; 35():93-101. PubMed ID: 1781426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs-induced gastrointestinal damage. Review.
    Arroyo M; Lanas A
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):249-59. PubMed ID: 16971869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L
    Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrointestinal side effects of non-steroidal anti-inflammatory drugs in high-risk patients--role of selective cyclooxygenase inhibitors].
    Prónai L
    Orv Hetil; 2001 Sep; 142(35):1899-905. PubMed ID: 11601177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
    Thomas J; Straus WL; Bloom BS
    Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.